Rebendenne, Antoine http://orcid.org/0000-0001-8913-837X
Roy, Priyanka http://orcid.org/0000-0003-2934-538X
Bonaventure, Boris
Chaves Valadão, Ana Luiza
Desmarets, Lowiese http://orcid.org/0000-0001-5077-3333
Arnaud-Arnould, Mary http://orcid.org/0000-0003-2799-1011
Rouillé, Yves
Tauziet, Marine
Giovannini, Donatella
Touhami, Jawida
Lee, Yenarae
DeWeirdt, Peter
Hegde, Mudra http://orcid.org/0000-0003-4530-4633
Urbach, Serge
Koulali, Khadija El
de Gracia, Francisco Garcia
McKellar, Joe
Dubuisson, Jean
Wencker, Mélanie
Belouzard, Sandrine
Moncorgé, Olivier http://orcid.org/0000-0003-0512-1824
Doench, John G. http://orcid.org/0000-0002-3707-9889
Goujon, Caroline http://orcid.org/0000-0001-8571-1108
Article History
Received: 23 May 2021
Accepted: 26 May 2022
First Online: 25 July 2022
Competing interests
: J.G.D. consults for Agios, Microsoft Research, Phenomic AI, BioNTech and Pfizer; J.G.D consults for and has equity in Tango Therapeutics. J.G.D.’s interests were reviewed and are managed by the Broad Institute in accordance with its conflict-of-interest policies. The other authors declare no competing interests.
Free to read: This content has been made available to all.